Evidence map›Paper›PMID 29222328›Full record

ArticleThe Journal of biological chemistry2018

Fructose and glucose can regulate mammalian target of rapamycin complex 1 and lipogenic gene expression via distinct pathways.

Yue Hu, Ivana Semova, Xiaowei Sun, Hong Kang, Satyapal Chahar, Anthony N Hollenberg, David Masson, Matthew D Hirschey, Ji Miao, Sudha B Biddinger

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. mTOR is a Key Protein Involved in the Metabolic Effects of Simple Sugars.International journal of molecular sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Yue HuFrom the Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115.
Ivana SemovaFrom the Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115.
Xiaowei SunFrom the Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115.
Hong KangFrom the Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115.
Satyapal ChaharFrom the Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115.
Anthony N HollenbergDivision of Endocrinology, Metabolism and Diabetes, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215.
David MassonINSERM Lipid Nutrition Cancer UMR 1231, 21000 Dijon, France, and.
Matthew D HirscheyDuke Molecular Physiology Institute and Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, North Carolina 27710.
Ji MiaoFrom the Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, ji.miao@childrens.harvard.edu.
Sudha B BiddingerFrom the Division of Endocrinology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, sudha.biddinger@childrens.harvard.edu.
Harvard University · USBoston Children's Hospital · USBeth Israel Deaconess Medical Center · USDuke University · USUniversité de Bourgogne · FR

Funding

COREPRESSOR REGULATION OF THYROID HORMONE ACTIONR01DK056123 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI HOLLENBERG, ANTHONY N · 2000 to 2023
$7.6M
Control of lipid metabolism in insulin resistant statesR01DK094162 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI BIDDINGER, SUDHA B · 2012 to 2015
$1.5M
Insulin Regulation of Liver X Receptor in Normal and Insulin Resistant StatesR00DK100539 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI MIAO, JI · 2016 to 2018
$747k
Corepressor Regulation of Nuclear Receptor ActionR56DK056123 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI HOLLENBERG, ANTHONY N · 2009 to 2009
$425k
Insulin Regulation of Liver X Receptor in Normal and Insulin Resistant StatesK99DK100539 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI MIAO, JI · 2013 to 2014
$180k
NIDDK NIH HHS K99 DK100539NIDDK NIH HHS L40 DK065607NIDDK NIH HHS R00 DK100539NIDDK NIH HHS R01 DK056123NIDDK NIH HHS R01 DK094162NIDDK NIH HHS R56 DK056123
6 · The paper itself

Abstract

Although calorically equivalent to glucose, fructose appears to be more lipogenic, promoting dyslipidemia, fatty liver disease, cardiovascular disease, and diabetes. To better understand how fructose induces lipogenesis, we compared the effects of fructose and glucose on mammalian target of rapamycin complex 1 (mTORC1), which appeared to have both positive and negative effects on lipogenic gene expression. We found that fructose acutely and transiently suppressed mTORC1 signaling

Indexed as

Gene Expression RegulationLipogenesisAnimalsFructoseGlucoseLiverMaleMechanistic Target of Rapamycin Complex 1MiceMice, Inbred C57BLMice, KnockoutSignal TransductionTriglyceridesFructoseGlucoseMechanistic Target of Rapamycin Complex 1Triglyceridesdyslipidemiafructoseglucoselipogenesismammalian target of rapamycin (mTOR)metabolic syndrome

Identifiers

PMID29222328
PMCPMC5808762
OpenAlexW2794435933

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.